Published in J Immunol on July 01, 1993
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev (1996) 2.77
Concepts in immunology and diagnosis of hydatid disease. Clin Microbiol Rev (2003) 2.77
Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect Immun (1999) 1.16
Immunoglobulin G1 (IgG1) and IgG3 antibodies are markers of progressive disease in leprosy. Infect Immun (1995) 1.14
Selective increases in antibody isotypes and immunoglobulin G subclass responses to secreted antigens in tuberculosis patients and healthy household contacts of the patients. Clin Diagn Lab Immunol (1995) 1.08
IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clin Exp Immunol (1998) 1.03
Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. J Allergy Clin Immunol (2015) 0.98
Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy. Immunology (1999) 0.96
Regulatory T cell subsets in filarial infection and their function. Front Immunol (2013) 0.90
In vitro production of IgG4 by peripheral blood mononuclear cells (PBMC): the contribution of committed B cells. Clin Exp Immunol (1998) 0.86
Increases in the levels of Coxiella burnetii-specific immunoglobulin G1 and G3 antibodies in acute Q fever and chronic Q fever. Clin Diagn Lab Immunol (1998) 0.83
Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy. Immunology (1999) 0.81
Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus. Clin Diagn Lab Immunol (1996) 0.80
The induction of T helper type 1 response by cytokine gene transfection protects mice against secondary hydatidosis. Parasitol Res (2008) 0.79
Brugia malayi adult low molecular weight IgG4-reactive antigens induce differential cytokine response in lymphocytes of endemic normal and asymptomatic microfilariae carriers in vitro. J Clin Immunol (2007) 0.77
Differences in humoral responses to the p24 antigen between Ethiopian and Swedish human immunodeficiency virus type 1-infected patients may suggest influences from a T-helper 2-like phenotype. Clin Diagn Lab Immunol (1997) 0.77
Relevance of ex vivo blood lymphocyte assay for in vivo lymphocyte function. Clin Exp Immunol (2005) 0.75
CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol (1999) 3.32
In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest (1993) 2.84
Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science (2014) 2.20
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun (2001) 2.09
Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis (2000) 2.05
Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest (1993) 2.00
An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science (1991) 1.86
Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador. J Infect Dis (1994) 1.85
Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity (1997) 1.84
Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis (2000) 1.82
Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J Infect Dis (1998) 1.76
Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients. J Exp Med (1990) 1.71
Interferon-gamma in the management of infectious diseases. Ann Intern Med (1995) 1.68
Tropical medicine. BMJ (2000) 1.67
A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis (2000) 1.53
Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J Infect Dis (1991) 1.52
High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis. J Infect Dis (1996) 1.51
Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis (1991) 1.49
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest (1997) 1.46
Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. J Infect Dis (1986) 1.45
Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+CD27- lymphocyte subpopulation. J Immunol (1995) 1.42
Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J Infect Dis (2000) 1.41
IL-4- and IL-5-secreting lymphocyte populations are preferentially stimulated by parasite-derived antigens in human tissue invasive nematode infections. J Immunol (1993) 1.39
Tropical pulmonary eosinophilia. Annu Rev Med (1992) 1.38
Onchocerciasis and immunity in humans: enhanced T cell responsiveness to parasite antigen in putatively immune individuals. J Infect Dis (1988) 1.36
Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J Infect Dis (1994) 1.34
Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol (1992) 1.33
Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun (2001) 1.32
Immunity to onchocerciasis: putative immune persons produce a Th1-like response to Onchocerca volvulus. J Infect Dis (1995) 1.31
A polymerase chain reaction assay for detection of the parasite Wuchereria bancrofti in human blood samples. Am J Trop Med Hyg (1996) 1.30
Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol Today (1991) 1.29
Parasite-specific anergy in human filariasis. Insights after analysis of parasite antigen-driven lymphokine production. J Clin Invest (1987) 1.28
Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies. J Immunol (1995) 1.28
CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur J Immunol (1995) 1.28
Filarial parasite-specific T cell lines: induction of IgE synthesis. J Immunol (1985) 1.26
Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J Infect Dis (1994) 1.24
Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest (1992) 1.24
Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis (1987) 1.22
Frequency analysis of IgE-secreting B lymphocytes in persons with normal or elevated serum IgE levels. J Immunol (1991) 1.19
Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis. Trop Med Int Health (2003) 1.18
IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol (2000) 1.18
Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci U S A (1989) 1.18
Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response. Infect Immun (1999) 1.16
Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol (1993) 1.13
Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults. Lancet (1984) 1.10
Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis. Exp Parasitol (1996) 1.10
Differentiation stimuli induce receptors for plasma fibronectin on the human myelomonocytic cell line HL-60. Blood (1984) 1.10
Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa. Arch Intern Med (1989) 1.10
Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis. Infect Immun (1997) 1.09
Immunoregulation in human lymphatic filariasis: the role of interleukin 10. Parasite Immunol (1995) 1.09
Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis (1993) 1.08
The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection. Am J Trop Med Hyg (1987) 1.08
Protective immunity in bancroftian filariasis. Selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area. J Clin Invest (1989) 1.07
An analysis of in vitro B cell immune responsiveness in human lymphatic filariasis. J Immunol (1987) 1.07
Circulating parasite antigen(s) in lymphatic filariasis: use of monoclonal antibodies to phosphocholine for immunodiagnosis. J Immunol (1987) 1.07
Elevated IL-10 mRNA expression and downregulation of Th1-type cytokines in microfilaraemic individuals with Wuchereria bancrofti infection. Parasite Immunol (1997) 1.05
Diminished monocyte function in microfilaremic patients with lymphatic filariasis and its relationship to altered lymphoproliferative responses. Infect Immun (2005) 1.05
Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun (2001) 1.05
Cytokine regulation of antigen-driven immunoglobulin production in filarial parasite infections in humans. J Clin Invest (1990) 1.05
Onchocerciasis in a nonendemic population: clinical and immunologic assessment before treatment and at the time of presumed cure. J Infect Dis (2000) 1.02
Regulation of IL-5 in onchocerciasis. A critical role for IL-2. J Immunol (1993) 1.01
Immunology of lymphatic filariasis. Parasite Immunol (2014) 0.99
IgE production in human helminth infection. Reciprocal interrelationship between IL-4 and IFN-gamma. J Immunol (1993) 0.99
Migration of a novel DQA1* allele (DQA1*0502) from African origin to North and South America. Hum Immunol (1995) 0.98
Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the South Pacific. Am J Trop Med Hyg (2001) 0.97
Acute tropical pulmonary eosinophilia. Characterization of the lower respiratory tract inflammation and its response to therapy. J Clin Invest (1987) 0.97
CD45RB expression defines two interconvertible subsets of human CD4+ T cells with memory function. Eur J Immunol (1994) 0.96
Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy. J Clin Invest (1991) 0.95
Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisoners of war. J Infect Dis (1988) 0.94
Cloning and characterization of a potentially protective chitinase-like recombinant antigen from Wuchereria bancrofti. Infect Immun (1994) 0.94
Early human infection with Onchocerca volvulus is associated with an enhanced parasite-specific cellular immune response. J Infect Dis (2001) 0.94
Schistosoma mansoni: resistance to reinfection in the rat. Exp Parasitol (1977) 0.94
Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment. Clin Infect Dis (2001) 0.93
Familial eosinophilia: clinical and laboratory results on a U.S. kindred. Am J Med Genet (1998) 0.93
Interdigital lesions and frequency of acute dermatolymphangioadenitis in lymphoedema in a filariasis-endemic area. Br J Dermatol (2006) 0.92
Cloning and characterization of a species-specific repetitive DNA sequence from Loa loa. Mol Biochem Parasitol (1991) 0.92
In utero exposure to Onchocerca volvulus: relationship to subsequent infection intensity and cellular immune responsiveness. Infect Immun (1996) 0.92
Evaluation of a polymerase chain reaction-based assay for diagnosis of Wuchereria bancrofti infection. J Infect Dis (1996) 0.92
Enumeration of IgE secreting B cells. A filter spot-ELISA. J Immunol Methods (1990) 0.91
Biochemical and immunologic characterization of a major IgE-inducing filarial antigen of Brugia malayi and implications for the pathogenesis of tropical pulmonary eosinophilia. J Immunol (1992) 0.91
Identification of eosinophils in lysed whole blood using side scatter and CD16 negativity. Cytometry (1997) 0.91
Persistent thyroid autoimmunity after subacute thyroiditis. J Clin Lab Immunol (1987) 0.90
Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function. J Clin Invest (1984) 0.90
A new TNFA promoter allele identified in South American Blacks. Immunogenetics (1996) 0.90
Lymphocyte subpopulations in Bancroftian filariasis: activated (DR+) CD8+ T cells in patients with chronic lymphatic obstruction. Clin Exp Immunol (1989) 0.90
Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin. J Infect Dis (1999) 0.89
Resistance to Onchocerca volvulus: differential cellular and humoral responses to a recombinant antigen, OvMBP20/11. J Infect Dis (1995) 0.89
Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. J Clin Invest (1991) 0.88
Identification of surface molecules associated with physiologic activation of eosinophils. Application of whole-blood flow cytometry to eosinophils. J Immunol (1996) 0.88
Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis. Clin Immunol (2000) 0.88
Biological role of helper T-cell subsets in helminth infections. Chem Immunol (1992) 0.88
Mammography of lymphatic filariasis. AJR Am J Roentgenol (1996) 0.88
Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. J Infect Dis (1994) 0.88
B cell responses to paramyosin. Isotypic analysis and epitope mapping of filarial paramyosin in patients with onchocerciasis. J Immunol (1990) 0.88
Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis (1994) 0.88
The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans. J Infect Dis (1989) 0.87